UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line
about
P1343
Human Papilloma Virus (HPV) Induced Head & Neck Squamous Cell Carcinoma: A Comprehensive RetrospectPrimary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancerComprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristicsRefining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.Head and neck cancer stem cells: the effect of HPV--an in vitro and mouse studyPatterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma.Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma.Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumorReliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancerMUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway.Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynx.Matted nodes as a predictor of distant metastasis in advanced-stage III/IV oropharyngeal squamous cell carcinoma.Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer.Human papillomavirus, p16, and epidermal growth factor receptor biomarkers and CT perfusion values in head and neck squamous cell carcinoma.NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas.Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts.Pretreatment serum xanthophyll concentrations as predictors of head and neck cancer recurrence and survival.Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53.Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instabilityIntegrated genomic and molecular characterization of cervical cancer.Epidemiology of head and neck squamous cell cancer among HIV-infected patients.Perivascular stem cell niche in head and neck cancerStem-like cells and therapy resistance in squamous cell carcinomasOncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinomaEstablishment of a novel human papillomavirus-negative and radiosensitive head and neck squamous cell carcinoma cell line.Novel method of cell line establishment utilizing fluorescence-activated cell sorting resulting in 6 new head and neck squamous cell carcinoma lines.Establishment and characterization of a human papillomavirus type 16-positive tonsillar carcinoma xenograft in BALB/c nude mice.Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis.Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis.Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.Genetic Mutation and Exosome Signature of Human Papilloma Virus Associated Oropharyngeal Cancer.Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines.Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma.5-aza-2'-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells.Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines.HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers.Human papillomavirus and p16 protein expression as prognostic biomarkers in mobile tongue cancer.
P2860
Q26798802-DA774B5C-81A3-4F57-A55B-6803F22EDA85Q27009148-74ACF413-EDD0-40AC-8B81-69F7E746A076Q28485279-4156E82D-3A58-4D40-9DAB-D8A06963AE43Q33863850-F0D334F8-6A12-46BF-B010-9427C7B2BE60Q33863903-1DF1A4C5-3FCC-4786-BC3B-7B02AE7E06FFQ33954449-F3CCA0E3-9F4F-42CA-862F-BAD96F9DEA18Q34076276-DAA45A12-1E3A-4430-AEFF-2A7421F49248Q34129454-C8F476E6-623E-4F5C-8D07-9494AD68DCF1Q34156288-B2E5E2D1-7F75-4269-A7ED-2D3653F59FF9Q34381590-F23ACAB1-22EF-442C-A462-C42CFD6EED62Q34385645-4F71C44C-B55B-4700-948A-D17659E8076DQ35209085-99F5C77B-EF65-495C-BF46-A7A2068B87ADQ35453467-A341A3B5-1D83-45E9-A7A5-63D1EE920BC2Q35648944-9434453D-5F6C-4D07-A07E-5F5D8E35A4FCQ35827866-691890C5-4F74-4A65-961D-4A68230FC98CQ36637164-284F47F2-503D-4130-8839-8169D61842C0Q36834960-2EBBBB3B-DF58-43CB-ABEF-C8289D6E95A3Q37317281-2AA237DC-CC68-4BC0-8FC4-C78063525754Q37550193-845E8A29-EF5C-42D0-8CCD-FDF2513CF157Q37706407-327E9875-0DD2-43A8-A2C1-4F1B5047ACACQ37722577-D86E0468-066A-4633-A3E4-32A1F153A98EQ38030287-A831D682-8019-4920-A3F4-9712D4103C59Q38041726-FDDEC659-5A63-46A8-81DA-F71F029305DBQ38885144-EB153A7B-FD09-4B96-B653-E0E0BFD75B71Q38898269-29854A33-7FA9-4B76-B3FC-1E8740EFE9CEQ38910205-06BC95DB-8D55-4D98-B575-2F640CA3F6B7Q38944279-B31712E6-EFEB-494D-9704-F83F554D3AB0Q38999029-D4427E62-EFFA-45EC-AB4A-8FC90F4B931AQ39006076-2CFF1D99-70AD-4F57-9336-70255F5D22B3Q39394303-6CF7923E-BF35-4D96-8E96-CB13FDEF90A4Q40255513-14A55961-9865-4459-B1DD-CC92DCBFA41CQ40319208-BE955188-3533-4ADA-950A-103B9FF30F48Q40611651-79BF9F7C-4977-4B74-806F-A3E190C904B6Q40651597-A4288CBD-32A1-44CF-82C3-465FBA114326Q44444441-52008B65-BD07-418C-9B18-C4A72D389E5CQ47549582-4A42F4AC-437F-4AC7-9E7B-D4BCB1FEF846Q47723245-1BBF1E6B-8E00-4B63-8CBF-807DEB5E9FA9
P2860
UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
UM-SCC-104: a new human papill ...... amous cell carcinoma cell line
@ast
UM-SCC-104: a new human papill ...... amous cell carcinoma cell line
@en
type
label
UM-SCC-104: a new human papill ...... amous cell carcinoma cell line
@ast
UM-SCC-104: a new human papill ...... amous cell carcinoma cell line
@en
prefLabel
UM-SCC-104: a new human papill ...... amous cell carcinoma cell line
@ast
UM-SCC-104: a new human papill ...... amous cell carcinoma cell line
@en
P2093
P2860
P356
P1433
P1476
UM-SCC-104: a new human papill ...... amous cell carcinoma cell line
@en
P2093
Alice L Tang
Carol R Bradford
Douglas B Chepeha
Heather Walline
Jay Stoerker
John H Owen
Jonathan B McHugh
Jung Je Park
Mark E Prince
Martin P Graham
P2860
P304
P356
10.1002/HED.21962
P4510
P577
2011-12-13T00:00:00Z